Kim, Jiwon
Yang, Jihyuk
Ahn, Suyeon
Choi, Yonghyun
Tanaka, Masayoshi
Jang, Jaehee
Cho, Yeongseon
Kim, Hong Nam
Lee, Hee-Young
Choi, Jonghoon https://orcid.org/0000-0003-3554-7033
Funding for this research was provided by:
NRF Korea (RS-2024-00343605)
Article History
Received: 12 October 2024
Revised: 6 January 2025
Accepted: 2 February 2025
First Online: 20 May 2025
Declarations
:
: Dr. Jonghoon Choi is the CEO/founder, Dr. Yonghyun Choi is the CTO, and Dr. Masayoshi Tanaka is the science advisor of the Feynman Institute of Technology at the Nanomedicine Corporation.